Skip to main content
. 2024 Mar 27;25(7):3733. doi: 10.3390/ijms25073733
ABD agonist-binding domain
AD Alzheimer’s disease
AMPAR α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor
amyloid-β
BDNF brain-derived neurotrophic factor
CaMKII camodulin kinase II
cAMP 3′,5′-adenosine monophosphate
cGMP 3′,5′-guanosine monophosphate
CNS central nervous system
CREB cAMP response element-binding protein
CTD carboxyl C-terminal domain
DYRK1A dual-specificity tyrosine-phosphorylation-regulated kinase 1
EAAT excitatory amino acid transporter
ERK1/2 extracellular signal-regulated protein kinase 1/2
FENM fluoroethylnormemantine
GABA γ-aminobutyric acid
HD Huntington’s disease
HEK-293 human embryonic kidney 293 cells
L-Dopa L-3,4-dihydroxyphenylalanine
LTD long-term depression
LTP long-term potentiation
MAPK mitogen-activated protein kinases
NMDAR N-methyl-d-aspartate receptor
PCP phencycline
PD Parkinson’s disease
PET positron emission tomography
PKA protein kinase A
PSD-95 post-synaptic density protein 95
PTSD post-traumatic stress disorder
RCPG G protein-coupled receptor
SANT sodium-coupled neutral amino acid transporter
tPA tissue-type plasminogen activator